DK0796609T3 - Middel mod alopecia - Google Patents

Middel mod alopecia

Info

Publication number
DK0796609T3
DK0796609T3 DK97104606T DK97104606T DK0796609T3 DK 0796609 T3 DK0796609 T3 DK 0796609T3 DK 97104606 T DK97104606 T DK 97104606T DK 97104606 T DK97104606 T DK 97104606T DK 0796609 T3 DK0796609 T3 DK 0796609T3
Authority
DK
Denmark
Prior art keywords
anticancer agents
present
antialopecia agent
antialopecia
agent
Prior art date
Application number
DK97104606T
Other languages
Danish (da)
English (en)
Inventor
Yokichi Matsui
Kyoya Takahata
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DK0796609T3 publication Critical patent/DK0796609T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels or liquid extracts in solid capsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/30—Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
    • A23F3/32—Agglomerating, flaking or tabletting or granulating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Fish Paste Products (AREA)
  • Tea And Coffee (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK97104606T 1996-03-18 1997-03-18 Middel mod alopecia DK0796609T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6118696 1996-03-18
JP9059494A JPH09309840A (ja) 1996-03-18 1997-03-13 抗脱毛症状剤

Publications (1)

Publication Number Publication Date
DK0796609T3 true DK0796609T3 (da) 2003-11-17

Family

ID=26400541

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97104606T DK0796609T3 (da) 1996-03-18 1997-03-18 Middel mod alopecia

Country Status (8)

Country Link
US (1) US6713093B2 (fr)
EP (1) EP0796609B1 (fr)
JP (1) JPH09309840A (fr)
AT (1) ATE248571T1 (fr)
DE (1) DE69724490T2 (fr)
DK (1) DK0796609T3 (fr)
ES (1) ES2206623T3 (fr)
PT (1) PT796609E (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4321957B2 (ja) * 2000-09-11 2009-08-26 株式会社資生堂 男性型脱毛に対する抑制剤
EP1317915A4 (fr) * 2000-09-11 2006-06-14 Shiseido Co Ltd Agents nourrissant les cheveux et procede de selection de ces agents
WO2005115425A1 (fr) * 2004-05-28 2005-12-08 Suntory Limited Composition comprenant de l'extrait de thé fermenté comme composant principal et ayant pour effet d'augmenter l'adiponectine
JP2007197387A (ja) * 2006-01-27 2007-08-09 Maruzen Pharmaceut Co Ltd テストステロン５α−レダクターゼ阻害剤
TWI386168B (zh) 2006-05-18 2013-02-21 Yakult Honsha Kk 番石榴葉萃取物粉末及其製造方法
PL2689774T3 (pl) 2011-03-21 2019-07-31 Broda Technologies Co., Ltd Kompozycje hydrożelowe zmieniające się odwracalnie pod wpływem temperatury
CN104127838A (zh) * 2014-07-05 2014-11-05 济南伟传信息技术有限公司 治疗癌症的中药方剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61137809A (ja) * 1984-12-07 1986-06-25 Sanai Kagaku Kogyo Kk 化粧品
US4717579A (en) 1986-05-07 1988-01-05 The Procter & Gamble Co. Flowable frozen tea mix concentrate which contains high levels of sugar
JPH03109313A (ja) * 1989-04-21 1991-05-09 Yukihiro Takahashi 養毛剤の製造法
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
JPH0640860A (ja) * 1992-07-16 1994-02-15 Takeo Kaneko 養毛料
TW290434B (fr) 1992-10-13 1996-11-11 House Food Industrial Co

Also Published As

Publication number Publication date
JPH09309840A (ja) 1997-12-02
EP0796609A2 (fr) 1997-09-24
EP0796609B1 (fr) 2003-09-03
US20020160058A1 (en) 2002-10-31
PT796609E (pt) 2004-01-30
DE69724490D1 (de) 2003-10-09
ATE248571T1 (de) 2003-09-15
ES2206623T3 (es) 2004-05-16
DE69724490T2 (de) 2004-07-08
EP0796609A3 (fr) 1999-03-03
US6713093B2 (en) 2004-03-30

Similar Documents

Publication Publication Date Title
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
IL138723A0 (en) Antitumor agent
ATE110963T1 (de) Mittel zur hemmung der alpha-amylase aktivität.
HU0102039D0 (en) Use of paclitaxel stabilized with albumin for the preparation of pharmaceutical compositions treating solid tumors and the pharmaceutical compositions obtained thereby
PL309334A1 (en) Synthetic catalytical scavenger of free radicals, preferably used as antioxidants in preventing and treating pathogenic states
PT1411938E (pt) Utilizacao da ciclopamina para a preparacao de um medicamento para o tratamento de psoriase
DE60026855D1 (de) Synergistische kombination von roflumilast und salmeterol
WO2001021259A3 (fr) Procedes et compositions de traitement des pathologies apparentees aux plaquettes
EP0417385A3 (en) Preventive and curative medicament against infection with influenza virus, containing tea or tea polyphenols
MXPA01012184A (es) Composicion dietetica o farmaceutica para utilizarse en la prevencion o tratamiento de la hiperoxaluria.
WO2002051433A3 (fr) Nouvelle utilisation de l'artemine, membre de la famille de ligands du facteur de croissance gdnf
WO2002098345A8 (fr) Utilisation d'un antioxydant pour le traitement et/ou la prevention des affections oculaires de surface
PT1040830E (pt) Medicamento para doencas neurodegenerativas
AU2001267882A1 (en) Preventives and remedies for diseases in association with demyelination
WO2002053106A3 (fr) Composition auto-antigene
EP0819433A3 (fr) Compositions pour améliorer l'efficacité de médicaments anti-cancéreux à l'aide de catéchine de thé et/ou de théaflavine
ES2077703T3 (es) Inhibidores de la glucosiltransferasa, asi como metodos para la prevencion de la caries dental y alimentos anticaries que utilizan estos inhibidores.
PT1102586E (pt) Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica
DK0796609T3 (da) Middel mod alopecia
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
PL354413A1 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts ofginkgo biloba
TR200102512T2 (tr) Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.
EP1297849A4 (fr) Agent curatif contre des maladies du nerf optique et analogue
EP0400219A3 (fr) Utilisation de créosote comme agent antispasmodique
WO1997033620A3 (fr) Compose pour traiter des tumeurs